Estrella Immunopharma, Inc.
ESLAW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001844417
No open-market purchases or sales by Estrella Immunopharma, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $249.2K in total; no superinvestor holds it.
Other share classesESLA
Superinvestors holding ESLAW, Q2 2026
No superinvestor reported holding ESLAW in Q2 2026.